Which reflux treatment works best? major trial to find out
NCT ID NCT07611162
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will compare five treatments for laryngopharyngeal reflux disease (LPRD) in 800 adults. Participants will receive either alginate, magaldrate, sucralfate, a proton pump inhibitor, or a special diet for three months. Researchers will measure symptom improvement to see which approach is most effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- alginate, magaldrate, sucralfate, proton pump inhibitors, and diet
- What this could lead to
- If successful, this study could identify which treatment works best for laryngopharyngeal reflux, helping doctors choose the most effective and tolerable option.
- What could go wrong
- This is a single trial with 800 participants, and results may not apply to everyone. The study hasn't started yet, so outcomes are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARYNGOPHARYNGEAL REFLUX DISEASE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Mons
Mons, 7000, Belgium